Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis-Reference-Cited by-同舟云学术

Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis

Published:2024-04-18 Issue:5 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Wagner Jamie L¹^ORCID,Jones Bruce M²,Stover Kayla R¹,Cleary John D³,Bland Christopher M⁴,Schipper Katie E³,Chastain Daniel B⁵,Barber Katie E¹

Affiliation:

1. Department of Pharmacy Practice, University of Mississippi School of Pharmacy , Jackson, Mississippi , USA

2. Department of Pharmacy, St Joseph's/Candler Health System, Inc , Savannah, Georgia , USA

3. Department of Pharmacy, St Dominic Jackson-Memorial Hospital , Jackson, Mississippi , USA

4. Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy , Savannah, Georgia , USA

5. Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy , Albany, Georgia , USA

Abstract

Abstract Daptomycin use for gram-positive infections has increased. This cost minimization analysis aimed to determine cost and/or time savings of daptomycin over vancomycin. The estimated hospital cost savings was US$166.41 per patient, and pharmacist time saved of almost 20 minutes per patient. Daptomycin has the potential to save both time and money.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae217/57262829/ofae217.pdf

Reference20 articles.

1. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort;Kullar;Pharmacotherapy,2012

2. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children;Liu;Clin Infect Dis,2011

3. Evaluation of pharmacist time dedicated to vancomycin dosing in adult patients using a 24-hour AUC nomogram or trough monitoring approach: a time motion study;Chung;Am J Health Syst Pharm,2022

4. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity;Darko;Pharmacotherapy,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time for Outpatient Parenteral Antimicrobial Therapy (OPAT) Coordination: Difficult to Quantify Due to Heterogeneity in OPAT Care Models;Clinical Infectious Diseases;2024-08-19

2. Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy;Open Forum Infectious Diseases;2024-07-25